Gates Foundation commits $2.5 billion for women's health
Bill Gates, chair of the foundation and co-founder of Microsoft Corp., also said in an interview that he recently spoke with President Donald Trump about the foundation's years-long work with the National Institutes of Health on a gene-based cure for HIV.
Trump was curious about the project, but Gates told him that the current level of backing was unknown.
"I said, 'No, it's still up in the air how much U.S. government support we'll get for that,'' Gates said he told the president. The White House did not immediately respond to a request for comment.
The Gates Foundation announcement provides the most detail yet on one area where the foundation plans to use its remaining funds before it shuts down in 2045. This tranche of money will focus on women's health, targeting critical areas that particularly hit women in low— and middle-income countries.
"Women's health continues to be ignored, underfunded, and sidelined,' Gates said in a statement earlier Monday. "Too many women still die from preventable causes or live in poor health. That must change.'
The Gates Foundation previously said it would spend $200 billion over the next 20 years to close out its operations, a quicker timeline than its original plan of shuttering 20 years after Gates' death.
The U.S. pulled out of the World Health Organization in January, then in March shut down the U.S. Agency for International Development, which managed tens of billions of dollars of foreign aid. The government has also made it more difficult for researchers to get funding, cutting staff across federal health agencies including the National Institutes of Health, the largest public funder of biomedical research.
"Certainly, there's been some short-term disruption and uncertainty,' Gates said in the interview.
Gates said that he also met with Health and Human Services Secretary Robert F. Kennedy, Jr. about two weeks ago and talked about things they could work together on.
Gates was optimistic about the future of U.S. research and development funding. "I really don't know that it's going to be that disrupted,' he said. "That may sound optimistic, and I may end up being wrong about that,' he added.
The billionaire, along with his former wife Melinda French Gates, have given $60.2 billion to the foundation through the end of 2024.
The foundation says its new spending will support a myriad of projects, including portable ultrasound machines used during pregnancy, contraception delivered via microneedle patches stuck on the skin and basic research on the microbiome. It called on other public and private entities to increase funding for women's health.
Industry support is particularly important, said Rasa Izadnegahdar, director of maternal, newborn, child nutrition and health at the Gates Foundation. Pharmaceutical companies have the expertise to take early research and move it through into product development, he said in an interview.
"We see this need for other bigger players to actually come along, particularly those in industry, to move this forward,' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Japan Times
2 days ago
- Japan Times
RFK Jr.'s mRNA decision may be his worst yet
U.S. Health Secretary Robert F. Kennedy Jr.'s decision to cancel $500 million in grants and contracts for mRNA vaccine development jeopardizes the health and safety of Americans — both now and for years to come. The Nobel Prize-winning technology enabled the first COVID-19 vaccines to be developed with breathtaking speed during the first year of the pandemic, ultimately saving millions of lives. Yet Kennedy spent years undermining confidence in mRNA, a misinformation campaign that he continued after he took office. Now, he's systematically dismantling the very infrastructure we need to respond to a future pandemic. The secretary justified the decision to abandon mRNA in a video full of falsehoods that was posted on his social media. He opened by claiming that the vaccines "don't perform well against viruses that infect the upper respiratory tract.' In fact, we have plenty of evidence, both from randomized controlled clinical trials and real-world studies, that COVID-19 shots save lives and reduce hospitalizations. And although we need to see more data, early signs suggest that Moderna's flu vaccine is comparable to — or even more effective than — existing flu vaccines based on older technologies. Of course, we'd love to have vaccines that work better — longer-lasting protection would be nice, as would the complete prevention of infections. But pulling funding for a proven technology like mRNA isn't the way to achieve those goals. Kennedy also claims that the design of mRNA vaccines — which expose the immune system to proteins the virus uses to infect us — is rendered useless by single mutations and that they encourage new mutations that can prolong pandemics. Both claims are false. All viruses accumulate tiny genetic changes over time, regardless of whether a vaccine exists. He ends by saying that scientific "experts' within the Department of Health and Human Services have determined that mRNA technology poses more risks than benefits for respiratory viruses — another claim that public health experts strongly dispute. "I've been in the business for 50 years, and I've never seen a more dangerous decision made by a government agency related to public health,' says Michael Osterholm, director of the University of Minnesota's Center for Infectious Disease Research and Policy. Says Osterholm, who has advised several administrations on pandemic preparedness, "There's no factual basis for what he's said.' Kennedy's hostility toward mRNA technology is no surprise. During the pandemic, he was cited by the Center for Countering Digital Hate as one of the "Disinformation Dozen,' a group of influencers responsible for the majority of the anti-vaccine content on Facebook, Instagram and Twitter — where he spread false claims about the dangers of the COVID-19 vaccine. Under his leadership, health agencies have already terminated a $766 million contract with Moderna to use mRNA technology to develop vaccines against flu viruses, including H5N1. He also unilaterally changed the recommendations for who should receive COVID-19 shots. This latest move has far-reaching implications for public health. First, he has enormous influence over a segment of the public: a recent poll by KFF found that 70% of Republicans trusted Kennedy to provide reliable information about vaccines. In other words, his misinformation-laden social media posts could meaningfully shape public attitudes about mRNA vaccines. More troubling, though, is how Kennedy is undermining the country's ability to address current and future pathogens. Abandoning mRNA vaccines will put Americans at a disadvantage if another pandemic occurs. "In a biological emergency, time is our greatest weapon,' says Jennifer Nuzzo, director of the Pandemic Center at the Brown University School of Public Health. The faster we respond, the fewer the harms - whether in terms of people dying or damage to economic prosperity and national security, Nuzzo says. The technology offers exceptional speed compared to conventional vaccine manufacturing methods such as whole-virus vaccines, which Kennedy says will be the focus of future development. Whole-virus vaccines are typically produced by growing the virus in chicken eggs, then extracting, inactivating and purifying it — a process that can take up to six months to complete. And the world also lacks sufficient egg-based manufacturing capacity. According to Osterholm, we can produce only about 2 billion shots in the first 18 months of a pandemic. In contrast, mRNA vaccines can go from concept to mass production in just a few months — and we've already seen that it's possible to produce enough to serve the global population within a year, he adds. To be clear, other countries are continuing to invest in mRNA, which means those vaccines will still be developed if another scary virus emerges. The next time around, however, Americans could be last in line to receive them. "Preparedness is a deterrent,' Nuzzo says. Walking away from an investment in mRNA also "sends a message to our adversaries that the United States is uncommitted to preparing for future health emergencies — that the United States is now more vulnerable than it has ever been because we are systematically taking off the table multiple approaches to protect ourselves.' What a terrifying thought. Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry.
Japan Times
5 days ago
- Japan Times
Gates Foundation commits $2.5 billion for women's health
The Gates Foundation will spend $2.5 billion over the next five years on projects related to women's health, just as the U.S. government pulls back on science research and international development. Bill Gates, chair of the foundation and co-founder of Microsoft Corp., also said in an interview that he recently spoke with President Donald Trump about the foundation's years-long work with the National Institutes of Health on a gene-based cure for HIV. Trump was curious about the project, but Gates told him that the current level of backing was unknown. "I said, 'No, it's still up in the air how much U.S. government support we'll get for that,'' Gates said he told the president. The White House did not immediately respond to a request for comment. The Gates Foundation announcement provides the most detail yet on one area where the foundation plans to use its remaining funds before it shuts down in 2045. This tranche of money will focus on women's health, targeting critical areas that particularly hit women in low— and middle-income countries. "Women's health continues to be ignored, underfunded, and sidelined,' Gates said in a statement earlier Monday. "Too many women still die from preventable causes or live in poor health. That must change.' The Gates Foundation previously said it would spend $200 billion over the next 20 years to close out its operations, a quicker timeline than its original plan of shuttering 20 years after Gates' death. The U.S. pulled out of the World Health Organization in January, then in March shut down the U.S. Agency for International Development, which managed tens of billions of dollars of foreign aid. The government has also made it more difficult for researchers to get funding, cutting staff across federal health agencies including the National Institutes of Health, the largest public funder of biomedical research. "Certainly, there's been some short-term disruption and uncertainty,' Gates said in the interview. Gates said that he also met with Health and Human Services Secretary Robert F. Kennedy, Jr. about two weeks ago and talked about things they could work together on. Gates was optimistic about the future of U.S. research and development funding. "I really don't know that it's going to be that disrupted,' he said. "That may sound optimistic, and I may end up being wrong about that,' he added. The billionaire, along with his former wife Melinda French Gates, have given $60.2 billion to the foundation through the end of 2024. The foundation says its new spending will support a myriad of projects, including portable ultrasound machines used during pregnancy, contraception delivered via microneedle patches stuck on the skin and basic research on the microbiome. It called on other public and private entities to increase funding for women's health. Industry support is particularly important, said Rasa Izadnegahdar, director of maternal, newborn, child nutrition and health at the Gates Foundation. Pharmaceutical companies have the expertise to take early research and move it through into product development, he said in an interview. "We see this need for other bigger players to actually come along, particularly those in industry, to move this forward,' he said.
Japan Times
29-07-2025
- Japan Times
Lakers' Luka Doncic shows off summer shred in Men's Health
After plenty of attention was brought to Luka Doncic's fitness level following his shocking February trade to the Los Angeles Lakers, the five-time All-Star has been putting another surprise together this offseason. After reports of an improved physique surfaced earlier this summer, a profile in Men's Health magazine confirmed the extent to which Doncic has gone to develop a slimmed-down look as he prepares for his first full season in L.A. Doncic, 26, has generally been listed at 6-foot-6 and 230 pounds, although opinions on the weight have varied. It did not prohibit him from scoring 28.2 points with 8.2 rebounds and 7.7 assists last season. But reports indicated this past winter that the Dallas Mavericks had become exasperated with Doncic's lack of fitness, which might have contributed to a calf injury that the star guard had been rehabbing for a month prior to the trade that shocked the NBA. Ankle, calf, knee and back injuries have slowed Doncic at certain times in his career, although he still managed to play at least 61 games in a season until he was reduced to 50 last year with the Mavericks and Lakers combined. Now, Doncic is visibly slimmer after an improved diet combined with a fitness program. He has been avoiding gluten and keeping sugar to a minimum, while loading up on protein to help him get through multiple workouts a day that include lifting weights along with on-court drills. "Obviously, be the best that I can be, take care of myself," Doncic said to Men's Health. "This year, with my team, I think we did a huge step. But this is just the start, you know. I need to keep going. Can't stop." While LeBron James exercised a contract option to return to the Lakers in 2025-26, the team also added center Deandre Ayton, guard Marcus Smart and forward Jake LaRavia. The profile did not mention Doncic's current weight, but photographs showed off his slim look with greater muscle definition in his arms. His workouts kept him away from basketball at first, then had him return to the court in June. He will play for Slovenia in EuroBasket in August. "So every summer I try my best to work on different things," he said. "Obviously, I'm very competitive. This summer was just a little bit different, you know. It kind of motivated me to be even better."
